Search - tctmd.com

Displaying 21 - 40 of 41

Sort: Relevancy | Date

News Conference News HFSA 2022

REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status

L.A. McKeown

October 07, 2022

GDMT With ARNI Lessens MR, Perhaps Obviating Need for Interventions

News Conference News HFSA 2022

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Michael O'Riordan

October 04, 2022

News Conference News HFSA 2022

Dapagliflozin’s Benefits Similar in HF Patients With Improved EF: DELIVER

Todd Neale

October 04, 2022

News Daily News HFSA 2021

In HF and Diabetes, Mobile Health App Modestly Boosts Physical Activity

Michael O'Riordan

September 15, 2021

News Conference News HFSA 2021

Digital App Improves HF Quality-of-Care Metrics: CONNECT-AF

Michael O'Riordan

September 14, 2021

News Conference News HFSA 2021

PRESERVED-HF: Dapagliflozin Improves Symptoms, Physical Limitations in HFpEF

Todd Neale

September 13, 2021

News Conference News HFSA 2020

Splanchnic Nerve Ablation Improves HFpEF Symptoms, QoL in FIH Study

L.A. McKeown

October 12, 2020

News Conference News HFSA 2020

EMBRACE HF: Empagliflozin Cuts PA Pressure in HF With or Without Diabetes

L.A. McKeown

October 09, 2020

More HF Readmissions Among Black People From Deprived Neighborhoods

News Conference News HFSA 2020

Old Dog, New Tricks? HOMAGE Hints at Role for Spironolactone in HF Prevention

L.A. McKeown

September 24, 2019

News Conference News HFSA 2019

Virtual Doctor Visits Reduce Missed Appointments After HF Hospitalizations: ViV-HF

L.A. McKeown

September 23, 2019

News Conference News HFSA 2019

New PROVE-HF Data May Reassure Clinicians of Sacubitril/Valsartan Benefit in HFrEF

L.A. McKeown

September 18, 2019

News Conference News HFSA 2019

DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF

L.A. McKeown

September 16, 2019

Conference HFSA 2025

HFSA 2025

Minneapolis, MN

September 26, 2025

September 29, 2025

Conference HFSA 2024

HFSA 2024

Atlanta, Georgia

September 29, 2024

September 30, 2024

Conference HFSA 2023

HFSA 2023

Cleveland, Ohio

October 06, 2023

October 09, 2023

Conference HFSA 2022

HFSA 2022

Washington, D.C.

September 30, 2022

October 03, 2022

Conference HFSA 2021

HFSA 2021

September 10, 2021

September 13, 2021

Conference HFSA 2020

HFSA 2020

September 30, 2020

October 06, 2020

Conference HFSA 2019

HFSA 2019

Philadelphia, PA

September 13, 2019

September 16, 2019

Advertisement

REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Dapagliflozin’s Benefits Similar in HF Patients With Improved EF: DELIVER

In HF and Diabetes, Mobile Health App Modestly Boosts Physical Activity

Digital App Improves HF Quality-of-Care Metrics: CONNECT-AF

PRESERVED-HF: Dapagliflozin Improves Symptoms, Physical Limitations in HFpEF

Splanchnic Nerve Ablation Improves HFpEF Symptoms, QoL in FIH Study

EMBRACE HF: Empagliflozin Cuts PA Pressure in HF With or Without Diabetes

More HF Readmissions Among Black People From Deprived Neighborhoods

Old Dog, New Tricks? HOMAGE Hints at Role for Spironolactone in HF Prevention

Virtual Doctor Visits Reduce Missed Appointments After HF Hospitalizations: ViV-HF

New PROVE-HF Data May Reassure Clinicians of Sacubitril/Valsartan Benefit in HFrEF

DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF

HFSA 2025

HFSA 2024

HFSA 2023

HFSA 2022

HFSA 2021

HFSA 2020

HFSA 2019

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content